Exact Mass: 384.142

Macrozamin

C13H24N2O11 (384.138)

Macrozamin is a glycoside. (Z)-methyl-oxido-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethylimino]ammonium is a natural product found in Macrozamia communis, Dioon spinulosum, and other organisms with data available. Macrozamin is a major constituent principle of Cycads. Macrozamin has carcinogenic, mutagenic, teratogenic and neurotoxic properties[1].

Elafibranor

C22H24O4S (384.1395)

Tetraphenylcyclopentadienone

C29H20O (384.1514)

Hymenoside T

C18H24O9 (384.142)

Spicatolide G

C18H24O9 (384.142)

Dodecamethylpentasiloxane

C12H36O4Si5 (384.146)

An organosiloxane that is pentasiloxane in which all the hydrogens have been replaced by methyl groups. Metabolite observed in cancer metabolism.

5-Chloro-3-[(1E)-3,4-dihydroxy-3,5-dimethyl-1-hepten-1-yl]-7,8-dihydroxy-7-methyl-7,8-dihydro-6H-isochromen-6-one

C19H25ClO6 (384.134)

Oprea1_459828

C21H24N2O3S (384.1508)

Tenuifoliside D

C18H24O9 (384.142)

Sinapaldehyde glucoside

C18H24O9 (384.142)

C19H25ClO6

C19H25ClO6 (384.134)

15G256nu

C18H24O9 (384.142)

creoside III

C18H24O9 (384.142)

ethyl 4-O-feruloyl-beta-glucopyranoside

C18H24O9 (384.142)

(E)-ethyl ferulate 4-O-beta-D-glucopyranoside

C18H24O9 (384.142)

5-epi-olguine

C18H24O9 (384.142)

(-)-4-hydroxybenzoicacid-4-O-[6-O-((2R)-methylbutyryl)-beta-D-glucopyranoside]

C18H24O9 (384.142)

regaloside J

C18H24O9 (384.142)

5-beta-D-glucopyranosyloxy-7-hydroxy-2-isopropylchromanone

C18H24O9 (384.142)

(2R,3S)-2-(3,4-dihydroxyphenyl)-3-acetylamino-7-(N-acetyl-2-aminoethylene)-1,4-benzodioxane

C20H20N2O6 (384.1321)

C18H24O9

C18H24O9 (384.142)

Asp Asn His

C14H20N6O7 (384.1393)

Asn His Asp

C14H20N6O7 (384.1393)

His Asn Asp

C14H20N6O7 (384.1393)

His Asp Asn

C14H20N6O7 (384.1393)

Asp His Asn

C14H20N6O7 (384.1393)

5-chloro-3-[(E)-3,4-dihydroxy-3,5-dimethylhept-1-enyl]-7,8-dihydroxy-7-methyl-8H-isochromen-6-one

C19H25ClO6 (384.134)

5-chloro-3-[(E)-3,4-dihydroxy-3,5-dimethylhept-1-enyl]-7,8-dihydroxy-7-methyl-8H-isochromen-6-one [IIN-based on: CCMSLIB00000846833]

C19H25ClO6 (384.134)

5-chloro-3-[(E)-3,4-dihydroxy-3,5-dimethylhept-1-enyl]-7,8-dihydroxy-7-methyl-8H-isochromen-6-one [IIN-based: Match]

C19H25ClO6 (384.134)

Asp Gly Gly His

C14H20N6O7 (384.1393)

Asp Gly His Gly

C14H20N6O7 (384.1393)

Asp His Gly Gly

C14H20N6O7 (384.1393)

Gly Asp Gly His

C14H20N6O7 (384.1393)

Gly Asp His Gly

C14H20N6O7 (384.1393)

Gly Gly Asp His

C14H20N6O7 (384.1393)

Gly Gly His Asp

C14H20N6O7 (384.1393)

Gly His Asp Gly

C14H20N6O7 (384.1393)

Gly His Gly Asp

C14H20N6O7 (384.1393)

His Asp Gly Gly

C14H20N6O7 (384.1393)

His Gly Asp Gly

C14H20N6O7 (384.1393)

His Gly Gly Asp

C14H20N6O7 (384.1393)

Asn Asp His

C14H20N6O7 (384.1393)

Ac-Phe-Gly-pNA

C19H20N4O5 (384.1434)

tetraphenylcyclopentadienone

C29H20O (384.1514)

Tetrakis(trimethylsilyl) orthosilicate

C12H36O4Si5 (384.146)

2-[4-(1,3-dioxolan-2-yl)phenyl]-5-methoxy-3-phenyl-1,6-naphthyridine

C24H20N2O3 (384.1474)

Diphenyl[bis(phenylethynyl)]silane

C28H20Si (384.1334)

methyl 4-((4-(tert-butoxycarbonyl)piperazinyl)sulfonyl)benzoate

C17H24N2O6S (384.1355)

4,4-(9H-Fluorene-9,9-diyl)bis(2-fluoroaniline)

C25H18F2N2 (384.1438)

(1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate

C21H24N2O3S (384.1508)

4-(3-CARBOXY-BENZENESULFONYL)-[1,4]DIAZEPANE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H24N2O6S (384.1355)

[[2(or 3)-(phenylmethyl)[1,1-biphenyl]-4-yl]oxy]-,sodium salt

C23H21NaO4 (384.1337)

FMOC-D-3-CHLOROPHENYLALANINE

C18H22F2N2O5 (384.1497)

ethyl 2-[2-(2-imidazol-1-yl-6-methylpyrimidin-4-yl)pyrrolidin-3-yl]-1,3-thiazole-4-carboxylate

C18H20N6O2S (384.1368)

bis(ethyl acetoacetato)(2,4-pentanedionato)aluminium

C17H25AlO8 (384.1365)

(4R,12aS)-3,4,6,8,12,12a-Hexahydro-4-methyl-6,8-dioxo-7-(phenylmethoxy)-2H-pyrido[1,2:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid

C20H20N2O6 (384.1321)

Elafibranor

C22H24O4S (384.1395)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Elafibranor (GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively.

Reldesemtiv

C19H18F2N6O (384.151)

C78281 - Agent Affecting Musculoskeletal System

1-Benzyl-3-(4-methoxyphenylamino)-4-phenylpyrrole-2,5-dione

C24H20N2O3 (384.1474)

GSK3987 is a pan LXRα/β agonist with EC50s of 50 nM, 40 nM for LXRα-SRC1 and LXRβ-SRC1, respectively. GSK3987 increases the expression of ABCA1 and SREBP-1c. GSK3987 induces cellular cholesterol efflux and triglyceride accumulation[1].

N-(3-(8-cyano-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazin-2-ylamino)phenyl)acetamide

C20H16N8O (384.1447)

4-{[4-(1-Cyclopropyl-2-Methyl-1h-Imidazol-5-Yl)pyrimidin-2-Yl]amino}-N-Methylbenzenesulfonamide

C18H20N6O2S (384.1368)

Sarizotan hydrochloride

C22H22ClFN2O (384.1405)

C26170 - Protective Agent > C1509 - Neuroprotective Agent

N-{3-Methyl-5-[2-(pyridin-4-ylamino)-ethoxy]-phenyl}-benzenesulfonamide

C20H22N3O3S+ (384.1382)

Ethyl ferulate-4-glucoside

C18H24O9 (384.142)

5,6-dimethoxy-3-[[(3-methoxyphenyl)-oxomethyl]amino]-1H-indole-2-carboxylic acid methyl ester

C20H20N2O6 (384.1321)

5-[(3,5-dimethyl-4-nitro-1-pyrazolyl)methyl]-N-[(4-methoxyphenyl)methyl]-2-furancarboxamide

C19H20N4O5 (384.1434)

[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]-[2-(ethylthio)phenyl]methanone

C21H24N2O3S (384.1508)

N-[(6-ethoxy-2-oxo-1H-quinolin-3-yl)methyl]-4-fluoro-N-(2-hydroxyethyl)benzamide

C21H21FN2O4 (384.1485)

1-(Diethylamino)-3-[(2-oxo-2-thiophen-2-ylethyl)thio]-5,6,7,8-tetrahydronaphthalene-2-carbonitrile

C21H24N2OS2 (384.133)

(2S)-2-(1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-2-yl)propanoic acid (4-oxo-1,2,3-benzotriazin-3-yl)methyl ester

C19H20N4O5 (384.1434)

5-chloro-3-[(E)-3,4-dihydroxy-3,5-dimethylhept-1-enyl]-7,8-dihydroxy-7-methyl-8H-isochromen-6-one

C19H25ClO6 (384.134)

Asp-His-Asn

C14H20N6O7 (384.1393)

N-(cyclopropylmethyl)-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(1-methyl-4-imidazolyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C16H24N4O5S (384.1467)

N-(cyclopropylmethyl)-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[(1-methyl-4-imidazolyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C16H24N4O5S (384.1467)

N-(cyclopropylmethyl)-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(1-methyl-4-imidazolyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C16H24N4O5S (384.1467)

2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C17H24N2O6S (384.1355)

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C17H24N2O6S (384.1355)

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C17H24N2O6S (384.1355)

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo(3-pyridinyl)methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H20N2O6 (384.1321)

1-[(1R,2aR,8bR)-2-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-methoxyethanone

C21H21FN2O4 (384.1485)

1-[(1R,2aS,8bS)-2-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-methoxyethanone

C21H21FN2O4 (384.1485)

N-(cyclopropylmethyl)-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(1-methyl-4-imidazolyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C16H24N4O5S (384.1467)

N-(cyclopropylmethyl)-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(1-methyl-4-imidazolyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C16H24N4O5S (384.1467)

N-(cyclopropylmethyl)-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(1-methyl-4-imidazolyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C16H24N4O5S (384.1467)

N-(cyclopropylmethyl)-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(1-methyl-4-imidazolyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C16H24N4O5S (384.1467)

N-(cyclopropylmethyl)-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[(1-methyl-4-imidazolyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C16H24N4O5S (384.1467)

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C17H24N2O6S (384.1355)

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C17H24N2O6S (384.1355)

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C17H24N2O6S (384.1355)

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C17H24N2O6S (384.1355)

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide

C17H24N2O6S (384.1355)

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo(3-pyridinyl)methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H20N2O6 (384.1321)

1-[(1S,2aS,8bS)-2-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-methoxyethanone

C21H21FN2O4 (384.1485)

1-[(1S,2aR,8bR)-2-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-methoxyethanone

C21H21FN2O4 (384.1485)

(1S,5R)-3-(3-methoxyphenyl)sulfonyl-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane

C21H24N2O3S (384.1508)

Asn-Asp-His

C14H20N6O7 (384.1393)

Asn-His-Asp

C14H20N6O7 (384.1393)

Asp-Asn-His

C14H20N6O7 (384.1393)

His-Asn-Asp

C14H20N6O7 (384.1393)

His-Asp-Asn

C14H20N6O7 (384.1393)

3,4,5-Trihydroxy-6-[1-(4-methoxyphenyl)-3-oxopentan-2-yl]oxyoxane-2-carboxylic acid

C18H24O9 (384.142)

3,4,5-Trihydroxy-6-[1-(4-methoxyphenyl)-3-oxopentoxy]oxane-2-carboxylic acid

C18H24O9 (384.142)

3,4,5-Trihydroxy-6-[5-(4-methoxyphenyl)-3-oxopentan-2-yl]oxyoxane-2-carboxylic acid

C18H24O9 (384.142)

Y16

C24H20N2O3 (384.1474)

Y16 is a specific inhibitor of Leukemia-associated Rho guanine nucleotide exchange factor (LARG) with a Kd value of 76 nM. Y16 is active in blocking the interaction of LARG and related G-protein-coupled Rho GEFs with RhoA. Y16 shows no detectable effect on other diffuse B-cell lymphoma (Dbl) family Rho GEFs, Rho effectors, or a RhoGAP[1].

7-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-5-methoxy-4,6-dimethyl-3h-2-benzofuran-1-one

C18H24O9 (384.142)

(3s,6s)-13-chloro-6,14-dihydroxy-16-methoxy-3-methyl-4,5,6,7,8,9,10,12-octahydro-3h-2-benzoxacyclotetradecine-1,11-dione

C19H25ClO6 (384.134)

[(3ar,11as)-10-(hydroxymethyl)-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-6-yl]methyl (2r)-3-chloro-2-hydroxy-2-methylpropanoate

C19H25ClO6 (384.134)

6-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-8-hydroxy-2,7-dimethyl-4a,8a-dihydrochromen-4-one

C18H24O9 (384.142)

(3s,4s)-4,8-dihydroxy-4-methyl-3-({[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydronaphthalen-1-one

C18H24O9 (384.142)

9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 2-methylpropanoate

C19H25ClO6 (384.134)

2-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl 4-hydroxybenzoate

C18H24O9 (384.142)

(3ar,4s,6ar,8s,9s,9as,9bs)-9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 2-methylpropanoate

C19H25ClO6 (384.134)

3-{[6-(benzyloxy)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-2,2-dimethyl-3-oxopropanoic acid

C18H24O9 (384.142)

5-chloro-3-(3,4-dihydroxy-3,5-dimethylhept-1-en-1-yl)-7,8-dihydroxy-7-methyl-8h-isochromen-6-one

C19H25ClO6 (384.134)

macrozemin

C13H24N2O11 (384.138)

(2e)-2-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl 4-hydroxybenzoate

C18H24O9 (384.142)

ethyl (2e)-3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate

C18H24O9 (384.142)

3-{[2-(benzyloxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-2,2-dimethyl-3-oxopropanoic acid

C18H24O9 (384.142)

(2s)-3-hydroxy-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl (2e)-3-phenylprop-2-enoate

C18H24O9 (384.142)

6-ethoxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C18H24O9 (384.142)

ethyl 3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate

C18H24O9 (384.142)

3-{[(2r,3r,4s,5r,6r)-2-(benzyloxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-2,2-dimethyl-3-oxopropanoic acid

C18H24O9 (384.142)

3-{[(2r,3r,4s,5s,6r)-2-(benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-2,2-dimethyl-3-oxopropanoic acid

C18H24O9 (384.142)

(2r,3s,4r,5r,6r)-6-ethoxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C18H24O9 (384.142)

4,8-dihydroxy-4-methyl-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydronaphthalen-1-one

C18H24O9 (384.142)

3-{[(2r,3s,4s,5r,6r)-6-(benzyloxy)-3,4,5-trihydroxyoxan-2-yl]methoxy}-2,2-dimethyl-3-oxopropanoic acid

C18H24O9 (384.142)

[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e)-4-hydroxy-2-methylbut-2-en-1-yl]oxy}oxan-2-yl]methyl 4-hydroxybenzoate

C18H24O9 (384.142)

5-chloro-3-[(3r,4r,5s)-3,4-dihydroxy-3,5-dimethylhept-1-en-1-yl]-7,8-dihydroxy-7-methyl-8h-isochromen-6-one

C19H25ClO6 (384.134)

7-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-5-methoxy-4,6-dimethyl-3h-2-benzofuran-1-one

C18H24O9 (384.142)

3-{[6-(benzyloxy)-3,4,5-trihydroxyoxan-2-yl]methoxy}-2,2-dimethyl-3-oxopropanoic acid

C18H24O9 (384.142)

(3,4,5-trihydroxyoxan-2-yl)methyl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C18H24O9 (384.142)

3-{[(2r,3s,4r,5r,6r)-6-(benzyloxy)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-2,2-dimethyl-3-oxopropanoic acid

C18H24O9 (384.142)

6-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-8-hydroxy-2,7-dimethyl-4a,8a-dihydrochromen-4-one

C18H24O9 (384.142)

(3r)-3-{2,4-dihydroxy-6-[(2r)-2-{[(3r)-3-hydroxybutanoyl]oxy}propyl]benzoyloxy}butanoic acid

C18H24O9 (384.142)

13-chloro-6,14-dihydroxy-16-methoxy-3-methyl-4,5,6,7,8,9,10,12-octahydro-3h-2-benzoxacyclotetradecine-1,11-dione

C19H25ClO6 (384.134)

(3s,6r)-13-chloro-6,14-dihydroxy-16-methoxy-3-methyl-4,5,6,7,8,9,10,12-octahydro-3h-2-benzoxacyclotetradecine-1,11-dione

C19H25ClO6 (384.134)

3-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl 3-phenylprop-2-enoate

C18H24O9 (384.142)

3-{[2-(benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-2,2-dimethyl-3-oxopropanoic acid

C18H24O9 (384.142)

3-(2,4-dihydroxy-6-{2-[(3-hydroxybutanoyl)oxy]propyl}benzoyloxy)butanoic acid

C18H24O9 (384.142)